As Liberal Democrats, we believe in universal access, clinical autonomy, local accountability, and innovation that serves the patient rather than the platform. Labour’s 10-year plan for the health ...

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the stocks that Jim Cramer shed light on. During the episode, Cramer ...

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024.

US tech firm Palantir has accused the BMA of putting ‘ideology over patient interest’ in its opposition to the company’s NHS ...

Controversial system requires local NHS investment to maximize productivity The benefits of the UK health sector's ...

Palantir Technologies Inc. (NASDAQ:PLTR) ranks among the 20 best fast growth stocks to invest in. On June 30, Palantir ...

Shares of Palantir Technologies (NASDAQ:PLTR) gained 6.03% over the past five trading sessions. Over the past month, the ...

The report for Data Integration Market is slated to expand from USD 17.58 billion in 2025 to USD 33.24 billion by 2030, at a CAGR of 13.6% over ...

Louis Mosley, the UK boss of the US tech giant, appeared before the Science, Innovation and Technology Committee on Tuesday.

Palantir's strong growth propelled the stock to incredible returns over the past year. Palantir Technologies (NASDAQ: PLTR) ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Palantir Technologies (PLTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.